Cv Sciences, Inc. (CVSI) Stock Price & Analysis
Cv Sciences, Inc. (CVSI) rose 0.00% to USD 0.03 as of June 10, 2026 at 02:01 UTC, according to Nexqual real-time market data.
CVSI last closed at USD 0.03; the session ranged USD 0.03–0.03 on volume of 78,700 shares. Market capitalization is $5.92M, with a 52-week range of USD 0.02–0.1 (OQB). Source: Nexqual, June 10, 2026 at 02:01 UTC.
Key Statistics (as of June 10, 2026 at 02:01 UTC)
| Price | USD 0.03 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.03 |
| Open | USD 0.03 |
| Day Range | USD 0.03 – 0.03 |
| 52-Week Range | USD 0.02 – 0.1 |
| Volume | 78,700 shares |
| Market Cap | $5.92M |
| Exchange | OQB |
Technical Analysis (CVSI)
Nexqual's technical model rates CVSI "SELL" based on 2 bullish and 6 bearish signals across 124 daily candles, as of June 10, 2026 at 02:01 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0.03) |
| MACD | -0 (negative) |
Analyst Ratings (CVSI)
Wall Street analysts rate CVSI "None", per Nexqual as of June 10, 2026 at 02:01 UTC.
| Consensus Rating | None |
|---|
Earnings (CVSI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2022-06-30 | USD -0.02 vs est -0.03 ▲ beat |
| 2022-03-31 | USD -0.03 vs est -0.03 ▲ beat |
| 2021-12-31 | USD -0.02 vs est -0.02 ▲ beat |
Source: Nexqual, June 10, 2026 at 02:01 UTC.
Financials & Fundamentals (CVSI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, June 10, 2026 at 02:01 UTC.
Financial Health Score (CVSI)
Nexqual rates Cv Sciences, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:01 UTC.
| Growth | Critical — Revenue -18% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (CVSI)
| Insider Ownership | +7.79% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 203.98M |
Source: Nexqual, June 10, 2026 at 02:01 UTC.
Leadership (CVSI)
Cv Sciences, Inc. is led by Joseph D. Dowling (age 68), CEO, Secretary & Director, per Nexqual as of June 10, 2026 at 02:01 UTC.
| CEO, Secretary & Director | Joseph D. Dowling (age 68) |
|---|---|
| Chief Financial Officer | Joerg Grasser (age 50) |
| Senior Vice President of Revenue Growth | Jesse Karagianes |
From Cv Sciences, Inc.'s Latest SEC 10-K Filing (filed 2026-03-26)
Key Strengths & Strategy (as disclosed to the SEC)
- These partnerships and our expansive distribution allow us to build consumer trust in our brand and products.
- In addition, we have developed relationships with hemp growers in the United States and purchase raw materials domestically as well.
Partnerships
- Mehmet Oz announced that the Center of Medicare and Medicaid Innovation (CMMI) is planning a model that would allow Medicare beneficiaries to receive hemp-derived CBD products at no charge if recommended by their physicians, with coverage of up to $500 in hemp-derived productions, presumably on an annual basis, potentially beginning as early as April 2026.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MRMD | MariMed Inc. | USD 0.07 | ▼ 3.95% |
| CANN | TREES Corporation | USD 0.02 | ▲ 30.43% |
| AMMJ | American Cannabis Company, Inc. | USD 0 | ▲ 0% |
| DOGP | Dogecoin Cash Inc. | USD 0.01 | ▼ 28.57% |
| CWBHF | Charlotte's Web Holdings Inc. | USD 0.41 | ▼ 6.02% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:01 UTC. This page is informational and not investment advice.